Your browser doesn't support javascript.
Toxic epidermal necrosis following Sinopharm COVID-19 vaccine (BBIBP-CorV): A case report and literature review.
Shakoei, Safoura; Hadizadeh, Alireza.
  • Shakoei S; Department of Dermatology Imam Khomeini Hospital complex, Tehran University of Medical Sciences (TUMS) Tehran Iran.
  • Hadizadeh A; Department of Dermatology Imam Khomeini Hospital complex, Tehran University of Medical Sciences (TUMS) Tehran Iran.
Clin Case Rep ; 10(12): e6726, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2157750
ABSTRACT
This study reports a patient developing TEN after the first dose of (BBIBP-CorV). He developed numerous purpuric and dusky patches with flaccid bullae and areas of epidermal detachment covered more than 30% of the body area within 6 days. After treatment with dexamethasone and cyclosporin, he recovered within 14 days.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Reviews Topics: Vaccines Language: English Journal: Clin Case Rep Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Reviews Topics: Vaccines Language: English Journal: Clin Case Rep Year: 2022 Document Type: Article